1. Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, et al. Global Burden of Disease Cancer Collaboration. 2019; Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol. 5:1749–1768. DOI:
10.1001/jamaoncol.2019.2996. PMID:
31560378. PMCID:
PMC6777271.
2. Vauthey JN, Lauwers GY, Esnaola NF, Do KA, Belghiti J, Mirza N, et al. 2002; Simplified staging for hepatocellular carcinoma. J Clin Oncol. 20:1527–1536. DOI:
10.1200/JCO.2002.20.6.1527. PMID:
11896101.
Article
3. Llovet JM, Brú C, Bruix J. 1999; Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 19:329–338. DOI:
10.1055/s-2007-1007122. PMID:
10518312.
Article
4. Ikai I, Yamaoka Y, Yamamoto Y, Ozaki N, Sakai Y, Satoh S, et al. 1998; Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis: proposal as a standard therapy. Ann Surg. 227:433–439. DOI:
10.1097/00000658-199803000-00016. PMID:
9527067. PMCID:
PMC1191282.
5. Zhang YF, Wei W, Guo ZX, Wang JH, Shi M, Guo RP. 2015; Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus. Jpn J Clin Oncol. 45:837–843. DOI:
10.1093/jjco/hyv089. PMID:
26079139.
Article
6. Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, et al. 2018; Diagnosis, staging, and management of Hepatocellular Carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 68:723–750. DOI:
10.1002/hep.29913. PMID:
29624699.
Article
7. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. 2008; Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 359:378–390. DOI:
10.1056/NEJMoa0708857. PMID:
18650514.
Article
8. Kojiro M, Nakahara H, Sugihara S, Murakami T, Nakashima T, Kawasaki H. 1984; Hepatocellular carcinoma with intra-atrial tumor growth. A clinicopathologic study of 18 autopsy cases. Arch Pathol Lab Med. 108:989–992. PMID:
6095786.
9. Wakayama K, Kamiyama T, Yokoo H, Kakisaka T, Kamachi H, Tsuruga Y, et al. 2013; Surgical management of hepatocellular carcinoma with tumor thrombi in the inferior vena cava or right atrium. World J Surg Oncol. 11:259. DOI:
10.1186/1477-7819-11-259. PMID:
24093164. PMCID:
PMC3851861.
Article
10. Kokudo T, Hasegawa K, Matsuyama Y, Takayama T, Izumi N, Kadoya M, et al. 2017; Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: a Japanese nationwide survey. Hepatology. 66:510–517. DOI:
10.1002/hep.29225. PMID:
28437844.
Article
11. Sakamoto K, Nagano H. 2018; Outcomes of surgery for hepatocellular carcinoma with tumor thrombus in the inferior vena cava or right atrium. Surg Today. 48:819–824. DOI:
10.1007/s00595-017-1619-2. PMID:
29279997.
Article
12. Li AJ, Zhou WP, Lin C, Lang XL, Wang ZG, Yang XY, et al. 2013; Surgical treatment of hepatocellular carcinoma with inferior vena cava tumor thrombus: a new classification for surgical guidance. Hepatobiliary Pancreat Dis Int. 12:263–269. DOI:
10.1016/S1499-3872(13)60043-0. PMID:
23742771.
Article
13. Asahara T, Itamoto T, Katayama K, Nakahara H, Hino H, Yano M, et al. 1999; Hepatic resection with tumor thrombectomy for hepatocellular carcinoma with tumor thrombi in the major vasculatures. Hepatogastroenterology. 46:1862–1869. PMID:
10430360.
15. Wang Y, Yuan L, Ge RL, Sun Y, Wei G. 2013; Survival benefit of surgical treatment for hepatocellular carcinoma with inferior vena cava/right atrium tumor thrombus: results of a retrospective cohort study. Ann Surg Oncol. 20:914–922. DOI:
10.1245/s10434-012-2646-2. PMID:
22956071.
Article
16. Koo JE, Kim JH, Lim YS, Park SJ, Won HJ, Sung KB, et al. 2010; Combination of transarterial chemoembolization and three-dimensional conformal radiotherapy for hepatocellular carcinoma with inferior vena cava tumor thrombus. Int J Radiat Oncol Biol Phys. 78:180–187. DOI:
10.1016/j.ijrobp.2009.07.1730. PMID:
19926229.
Article
17. Li Y, Liu F, Yang L, Meng Y, Li A, Pan M. 2019; External-beam radiation therapy versus surgery in the treatment of hepatocellular carcinoma with inferior vena cava/right atrium tumor thrombi. Asia Pac J Clin Oncol. 15:316–322. DOI:
10.1111/ajco.13194. PMID:
31309718.
Article
18. Kokudo T, Hasegawa K, Yamamoto S, Shindoh J, Takemura N, Aoki T, et al. 2014; Surgical treatment of hepatocellular carcinoma associated with hepatic vein tumor thrombosis. J Hepatol. 61:583–588. DOI:
10.1016/j.jhep.2014.04.032. PMID:
24798618.
Article
19. Chen ZH, Zhang XP, Wang K, Sun JX, Chai ZT, Yang Y, et al. 2019; Liver resection versus transcatheter arterial chemoembolization for the treatment of patients with hepatocellular carcinoma and hepatic vein or inferior vena cava tumor thrombus: a propensity score matching analysis. Hepatol Res. 49:441–452. DOI:
10.1111/hepr.13297. PMID:
30549370.
Article
20. Kasai Y, Hatano E, Seo S, Taura K, Yasuchika K, Okajima H, et al. 2017; Proposal of selection criteria for operative resection of hepatocellular carcinoma with inferior vena cava tumor thrombus incorporating hepatic arterial infusion chemotherapy. Surgery. 162:742–751. DOI:
10.1016/j.surg.2017.05.011. PMID:
28705491.
Article